IHL 0.00% 4.1¢ incannex healthcare limited

Ann: Incannex Development Update for IHL-42X, page-19

  1. 1,235 Posts.
    lightbulb Created with Sketch. 1543
    Hi Ma420

    I know you asked @thevinnys but thought I'd chime in with the part I can answer.
    The CMAX trial is separate from the phase 2/3 pivotal trials. It is a bioavailability/bioequivalence study that I don't think any of us had on our radars for this development program, until today.

 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.